Huaier relieves oxaliplatin-induced hepatotoxicity through activation of the PI3K/AKT/Nrf2 signaling pathway in C57BL/6 mice
Article in Heliyon (September 2024)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Risk of immune system and skin and subcutaneous tissue related adverse events associated with oxaliplatin combined with immune checkpoint inhibitors: a pharmacovigilance study
Article in Frontiers in Pharmacology (June 2024)
High-dose oxaliplatin induces severe hypersensitivity reactions and high recurrence rates during rechallenge in patients treated with hepatic arterial infusion chemotherapy
Article in International Immunopharmacology (March 2024)